Some PharmaCare plans provide coverage for select oral and parenteral formulations (1000 micrograms [mcg]/mL)
Side-by-Side: DAC vs No-DAC | Side Effect | DAC | No-DAC | |---|---|---| | Flushing | Moderate | Mild | | Headache | Mild | Mild | | Water retention | Mild to moderate | Minimal | | Tingling | Reported more | Reported less | | Vivid dreams | Reported less | Reported more | | Insulin sensitivity over time | Higher theoretical concern | Lower | And for the record, here's what CJC-1295 does not typically cause at compounded doses: significant cortisol elevation, significant prolactin elevation, severe hunger spikes (that's GHRP-6's territory), mood changes, acute hypoglycemia, or acromegalic changes
Metabolic: IGF-1 elevation requires monitoring
Supporting glow-focused routines worldwide Youre viewing an SSL Secured Site with the McAfee Secure Protection
These include GSH, cysteine, bucillamine, cysteamine, dimercaprol, penicillamine, 2-mercaptoethanesulfonic acid (mesna), and amifostine